Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

Kyungpook National University

Status: Not yet enrolling

Conditions: Carbapenem-Resistant Enterobacteriaceae Colonization

Treatments: Combination Product: Placebo; Combination Product: Fecal Microbial transplant Capsules

Study type: Interventional

Funder types: Other

Identifiers

NCT07265817

KNUH 2023-07-013

Details and patient eligibility

About

The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.

Enrollment: 60 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have positive results in PCR or culture of rectal swab.

Exclusion criteria

• Not provide a consent.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

60 participants in 2 patient groups, including a placebo group

Fecal microbiota transplantation group

Active Comparator group

Treatment:

Combination Product: Fecal Microbial transplant Capsules

Placebo

Placebo Comparator group

Treatment:

Combination Product: Placebo